Applied DNA Sciences Inc Current Ratio 2010-2025 | APDN
Applied DNA Sciences Inc current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Applied DNA Sciences Inc Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2025-03-31 |
$0.01B |
$0.00B |
4.45 |
| 2024-12-31 |
$0.01B |
$0.00B |
4.73 |
| 2024-09-30 |
$0.01B |
$0.00B |
3.36 |
| 2024-06-30 |
$0.01B |
$0.00B |
3.91 |
| 2024-03-31 |
$0.00B |
$0.00B |
1.66 |
| 2023-12-31 |
$0.01B |
$0.00B |
1.77 |
| 2023-09-30 |
$0.01B |
$0.00B |
2.86 |
| 2023-06-30 |
$0.01B |
$0.00B |
4.23 |
| 2023-03-31 |
$0.02B |
$0.00B |
4.21 |
| 2022-12-31 |
$0.02B |
$0.00B |
5.51 |
| 2022-09-30 |
$0.02B |
$0.00B |
4.77 |
| 2022-06-30 |
$0.01B |
$0.00B |
2.16 |
| 2022-03-31 |
$0.01B |
$0.00B |
3.07 |
| 2021-12-31 |
$0.01B |
$0.00B |
2.85 |
| 2021-09-30 |
$0.01B |
$0.00B |
3.45 |
| 2021-06-30 |
$0.01B |
$0.00B |
8.70 |
| 2021-03-31 |
$0.02B |
$0.00B |
8.18 |
| 2020-12-31 |
$0.01B |
$0.00B |
2.24 |
| 2020-09-30 |
$0.01B |
$0.00B |
2.13 |
| 2020-06-30 |
$0.01B |
$0.00B |
4.97 |
| 2020-03-31 |
$0.01B |
$0.00B |
5.39 |
| 2019-12-31 |
$0.01B |
$0.00B |
6.39 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.96 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.81 |
| 2019-03-31 |
$0.00B |
$0.00B |
1.25 |
| 2018-12-31 |
$0.01B |
$0.00B |
1.68 |
| 2018-09-30 |
$0.00B |
$0.00B |
1.42 |
| 2018-06-30 |
$0.01B |
$0.00B |
1.55 |
| 2018-03-31 |
$0.01B |
$0.00B |
2.74 |
| 2017-12-31 |
$0.01B |
$0.00B |
5.29 |
| 2017-09-30 |
$0.01B |
$0.00B |
4.82 |
| 2017-06-30 |
$0.01B |
$0.00B |
3.39 |
| 2017-03-31 |
$0.01B |
$0.00B |
3.03 |
| 2016-12-31 |
$0.01B |
$0.00B |
3.34 |
| 2016-09-30 |
$0.01B |
$0.00B |
2.78 |
| 2016-06-30 |
$0.01B |
$0.00B |
4.00 |
| 2016-03-31 |
$0.02B |
$0.00B |
5.57 |
| 2015-12-31 |
$0.02B |
$0.00B |
7.61 |
| 2015-09-30 |
$0.01B |
$0.00B |
4.33 |
| 2015-06-30 |
$0.01B |
$0.00B |
8.02 |
| 2015-03-31 |
$0.00B |
$0.00B |
1.38 |
| 2014-12-31 |
$0.00B |
$0.00B |
2.40 |
| 2014-09-30 |
$0.00B |
$0.00B |
0.61 |
| 2014-06-30 |
$0.00B |
$0.00B |
1.69 |
| 2014-03-31 |
$0.00B |
$0.00B |
1.56 |
| 2013-12-31 |
$0.01B |
$0.00B |
3.31 |
| 2013-09-30 |
$0.01B |
$0.00B |
6.46 |
| 2013-06-30 |
$0.00B |
$0.00B |
1.67 |
| 2013-03-31 |
$0.01B |
$0.00B |
5.98 |
| 2012-12-31 |
$0.00B |
$0.00B |
1.73 |
| 2012-09-30 |
$0.00B |
$0.00B |
1.86 |
| 2012-06-30 |
$0.00B |
$0.00B |
2.76 |
| 2012-03-31 |
$0.00B |
$0.00B |
1.89 |
| 2011-12-31 |
$0.00B |
$0.00B |
0.57 |
| 2011-09-30 |
$0.00B |
$0.00B |
0.67 |
| 2011-06-30 |
$0.00B |
$0.01B |
0.06 |
| 2011-03-31 |
$0.00B |
$0.00B |
0.08 |
| 2010-12-31 |
$0.00B |
$0.00B |
0.19 |
| 2010-09-30 |
$0.00B |
$0.00B |
0.09 |
| 2010-06-30 |
$0.00B |
$0.00B |
0.06 |
| 2010-03-31 |
$0.00B |
$0.00B |
0.04 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.02 |
| 2009-09-30 |
$0.00B |
$0.00B |
0.10 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.14 |
| 2009-03-31 |
$0.00B |
$0.00B |
0.28 |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.000B |
$0.003B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
